Oklo’s cash burn for Q1 remained on track with management’s expectations. The company ended the quarter with a strong balance ...

His death marked the end of a long-standing debate over his eligibility for baseball’s highest honor, as players on the ineligible list had been barred from Hall of Fame consideration since a rule ...

Investing.com -- European Central Bank (ECB) policymaker Francois Villeroy de Galhau indicated in a recent interview that there may be room for another rate cut by the ECB by the summer. The ...

Based on the robust Q1 results, Exelixis raised its full-year 2025 revenue guidance to $2.25-$2.35 billion, up from its previous forecast of $2.15-$2.25 billion. The new guidance surpasses the current ...

The healthcare company, focused on early cancer detection, reported a Q1 loss of $3.10 per share, beating analyst estimates of a $4.26 loss. Revenue for the quarter came in at $31.8 million, up 19% ...

The U.S. Food and Drug Administration (FDA) today initiated a process to withdraw concentrated ingestible fluoride prescription drug products for children from the market. Unlike fluoride toothpaste ...